Literature DB >> 10594626

Q-Switched ruby laser therapy of acquired bilateral nevus of Ota-like macules.

S Kunachak1, P Leelaudomlipi, V Sirikulchayanonta.   

Abstract

BACKGROUND: Acquired bilateral nevus of Ota-like macules (ABNLM), also called nevus fuscoceruleus zygomaticus or nevus of Hori, is a relatively common disease in Asia. It is refractory to all medical treatment.
OBJECTIVE: To present the first report on the use of Q-switched ruby laser to treat ABNLM.
METHODS: One hundred and forty female patients, ages 19-62 years (mean 39 years), were included in the study. The laser fluence employed was 7-10 J/cm2, at a repetition rate of 1 Hz, and with a spot size of 2-4 mm. The number of treatment sessions ranged from 1 to 6 (mean 2.3).
RESULTS: Nine patients were lost to follow-up before complete clearance of the lesions, while in the remaining 131 patients complete clearance was obtained. The only complication was a long-term hypopigmentation, observed in three patients. There was no recurrence at 6 months- 4.3 years (mean 2.5 years) of follow-up.
CONCLUSION: Q-switched ruby laser is an effective and less invasive tool to eradicate ABNLM.

Entities:  

Mesh:

Year:  1999        PMID: 10594626     DOI: 10.1046/j.1524-4725.1999.99176.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  2 in total

1.  Novel treatment of Hori's nevus: A combination of fractional nonablative 2,940-nm Er:YAG and low-fluence 1,064-nm Q-switched Nd:YAG laser.

Authors:  Brian Wei Cheng Anthony Tian
Journal:  J Cutan Aesthet Surg       Date:  2015 Oct-Dec

2.  Comparison of characteristics of acquired bilateral nevus of Ota-like macules and nevus of Ota according to therapeutic outcome.

Authors:  Bangjin Lee; You Chan Kim; Won Hyoung Kang; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.